- 関
- testosterone 5-alpha-reductase、testosterone 5alpha-reductase
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/12/12 21:38:54」(JST)
[Wiki en表示]
Steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2) |
Identifiers |
Symbols |
SRD5A2 ; MGC138457 |
External IDs |
OMIM: 607306 MGI: 2150380 HomoloGene: 37292 ChEMBL: 1856 GeneCards: SRD5A2 Gene |
EC number |
1.3.1.22 |
Gene ontology |
Molecular function |
• 3-oxo-5-alpha-steroid 4-dehydrogenase activity
• sterol 5-alpha reductase activity
• amide binding
• cholestenone 5-alpha-reductase activity
|
Cellular component |
• endoplasmic reticulum membrane
• integral component of membrane
• neuronal cell body
• cell body fiber
|
Biological process |
• androgen biosynthetic process
• steroid catabolic process
• cell-cell signaling
• steroid metabolic process
• androgen metabolic process
• male gonad development
• biphenyl metabolic process
• dibenzo-p-dioxin metabolic process
• phthalate metabolic process
• hippocampus development
• hypothalamus development
• cell differentiation
• male genitalia development
• female genitalia development
• response to nutrient levels
• response to follicle-stimulating hormone
• response to testosterone
• response to drug
• response to peptide hormone
• small molecule metabolic process
• oxidation-reduction process
• bone development
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
6716 |
94224 |
Ensembl |
ENSG00000277893 |
ENSMUSG00000038541 |
UniProt |
P31213 |
Q99N99 |
RefSeq (mRNA) |
NM_000348 |
NM_053188 |
RefSeq (protein) |
NP_000339 |
NP_444418 |
Location (UCSC) |
Chr 2:
31.52 – 31.58 Mb |
Chr 17:
74.02 – 74.05 Mb |
PubMed search |
[1] |
[2] |
|
3-oxo-5-alpha-steroid 4-dehydrogenase 2 is an enzyme that in humans is encoded by the SRD5A2 gene.[1][2]
Steroid 5-alpha reductase catalyzes the conversion of the male sex hormone testosterone into the more potent androgen, dihydrotestosterone.
This gene encodes a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The encoded protein is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in this gene can result in male pseudohermaphroditism, specifically pseudovaginal perineoscrotal hypospadias (PPSH).[2]
See also
References
- ^ Thigpen AE, Davis DL, Milatovich A, Mendonca BB, Imperato-McGinley J, Griffin JE, Francke U, Wilson JD, Russell DW (Oct 1992). "Molecular genetics of steroid 5 alpha-reductase 2 deficiency". J Clin Invest 90 (3): 799–809. doi:10.1172/JCI115954. PMC 329933. PMID 1522235.
- ^ a b "Entrez Gene: SRD5A2 steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)".
Further reading
- Thigpen AE, Davis DL, Gautier T, et al. (1992). "Brief report: the molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred.". N. Engl. J. Med. 327 (17): 1216–9. doi:10.1056/NEJM199210223271706. PMID 1406794.
- Labrie F, Sugimoto Y, Luu-The V, et al. (1992). "Structure of human type II 5 alpha-reductase gene.". Endocrinology 131 (3): 1571–3. doi:10.1210/en.131.3.1571. PMID 1505484.
- Andersson S, Berman DM, Jenkins EP, Russell DW (1991). "Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.". Nature 354 (6349): 159–61. doi:10.1038/354159a0. PMID 1944596.
- Boudon C, Lobaccaro JM, Lumbroso S, et al. (1995). "A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5 alpha-reductase deficiency.". Clin. Endocrinol. (Oxf) 43 (2): 183–8. doi:10.1111/j.1365-2265.1995.tb01913.x. PMID 7554313.
- Thigpen AE, Silver RI, Guileyardo JM, et al. (1993). "Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.". J. Clin. Invest. 92 (2): 903–10. doi:10.1172/JCI116665. PMC 294929. PMID 7688765.
- Cai LQ, Zhu YS, Katz MD, et al. (1996). "5 alpha-reductase-2 gene mutations in the Dominican Republic.". J. Clin. Endocrinol. Metab. 81 (5): 1730–5. doi:10.1210/jc.81.5.1730. PMID 8626825.
- Hochberg Z, Chayen R, Reiss N, et al. (1996). "Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency.". J. Clin. Endocrinol. Metab. 81 (8): 2821–7. doi:10.1210/jc.81.8.2821. PMID 8768837.
- Vilchis F, Canto P, Chávez B, et al. (1997). "Molecular analysis of the 5 alpha-steroid reductase type 2 gene in a family with deficiency of the enzyme.". Am. J. Med. Genet. 69 (1): 69–72. doi:10.1002/(SICI)1096-8628(19970303)69:1<69::AID-AJMG13>3.0.CO;2-M. PMID 9066886.
- Anwar R, Gilbey SG, New JP, Markham AF (1997). "Male pseudohermaphroditism resulting from a novel mutation in the human steroid 5 alpha-reductase type 2 gene (SRD5A2).". MP, Mol. Pathol. 50 (1): 51–2. doi:10.1136/mp.50.1.51. PMC 379579. PMID 9208814.
- Can S, Zhu YS, Cai LQ, et al. (1998). "The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred.". J. Clin. Endocrinol. Metab. 83 (2): 560–9. doi:10.1210/jc.83.2.560. PMID 9467575.
- Nordenskjöld A, Ivarsson SA (1998). "Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family.". J. Clin. Endocrinol. Metab. 83 (9): 3236–8. doi:10.1210/jc.83.9.3236. PMID 9745434.
- Nordenskjöld A, Magnus O, Aagenaes O, Knudtzon J (1999). "Homozygous mutation (A228T) in the 5alpha-reductase type 2 gene in a boy with 5alpha-reductase deficiency: genotype-phenotype correlations.". Am. J. Med. Genet. 80 (3): 269–72. doi:10.1002/(SICI)1096-8628(19981116)80:3<269::AID-AJMG18>3.0.CO;2-T. PMID 9843052.
- Nnane IP, Kato K, Liu Y, et al. (1999). "Inhibition of androgen synthesis in human testicular and prostatic microsomes and in male rats by novel steroidal compounds.". Endocrinology 140 (6): 2891–7. doi:10.1210/en.140.6.2891. PMID 10342882.
- Makridakis NM, Ross RK, Pike MC, et al. (1999). "Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.". Lancet 354 (9183): 975–8. doi:10.1016/S0140-6736(98)11282-5. PMID 10501358.
- Vilchis F, Méndez JP, Canto P, et al. (2000). "Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency.". Clin. Endocrinol. (Oxf) 52 (3): 383–7. doi:10.1046/j.1365-2265.2000.00941.x. PMID 10718838.
- Hellwinkel OJ, Müller A, Struve D, Hiort O (2000). "Influence of androgens and age on androgen receptor and 5 alpha-reductase II transcription.". Eur. J. Endocrinol. 143 (2): 217–25. doi:10.1530/eje.0.1430217. PMID 10913941.
- Chávez B, Valdez E, Vilchis F (2000). "Uniparental disomy in steroid 5alpha-reductase 2 deficiency.". J. Clin. Endocrinol. Metab. 85 (9): 3147–50. doi:10.1210/jc.85.9.3147. PMID 10999800.
- Kim KS, Liu W, Cunha GR, et al. (2002). "Expression of the androgen receptor and 5 alpha-reductase type 2 in the developing human fetal penis and urethra.". Cell Tissue Res. 307 (2): 145–53. doi:10.1007/s004410100464. PMID 11845321.
- Hiort O, Schütt SM, Bals-Pratsch M, et al. (2002). "A novel homozygous disruptive mutation in the SRD5A2-gene in a partially virilized patient with 5alpha-reductase deficiency.". Int. J. Androl. 25 (1): 55–8. doi:10.1046/j.1365-2605.2002.00325.x. PMID 11869378.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
Oxidoreductases: CH–CH oxidoreductases (EC 1.3)
|
|
1.3.1: NAD/NADP acceptor |
- Enoyl-acyl carrier protein reductase/Enoyl ACP reductase
- 7-Dehydrocholesterol reductase
- Biliverdin reductase
- 2,4 Dienoyl-CoA reductase
|
|
1.3.3: Oxygen acceptor |
- Dihydroorotate dehydrogenase
- Coproporphyrinogen III oxidase
- Protoporphyrinogen oxidase
- Bilirubin oxidase
- Acyl-CoA oxidase
- Dihydrouracil oxidase
- Tetrahydroberberine oxidase
- Secologanin synthase
- Tryptophan alpha,beta-oxidase
- Pyrroloquinoline-quinone synthase
- L-galactonolactone oxidase
|
|
1.3.5: Quinone |
|
|
1.3.99: Other acceptors |
- Fumarate reductase
- Butyryl-CoA dehydrogenase
- Acyl CoA dehydrogenase
- 5α-reductase
- Glutaryl-CoA dehydrogenase
- Isovaleryl coenzyme A dehydrogenase
|
|
- Biochemistry overview
- Enzymes overview
- By EC number: 1.1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 10
- 11
- 13
- 14
- 15-18
- 2.1
- 3.1
- 4.1
- 5.1
- 6.1-3
|
|
|
|
Metabolism: lipid metabolism – ketones/cholesterol synthesis enzymes/steroid metabolism
|
|
Mevalonate pathway |
To HMG-CoA |
- Acetyl-Coenzyme A acetyltransferase
- HMG-CoA synthase (regulated step)
|
|
Ketogenesis |
- HMG-CoA lyase
- 3-hydroxybutyrate dehydrogenase
- Thiophorase
|
|
To Mevalonic acid |
|
|
To DMAPP |
- Mevalonate kinase
- Phosphomevalonate kinase
- Pyrophosphomevalonate decarboxylase
- Isopentenyl-diphosphate delta isomerase
|
|
Geranyl- |
- Dimethylallyltranstransferase
- Geranyl pyrophosphate
|
|
|
To cholesterol |
To lanosterol |
- Farnesyl-diphosphate farnesyltransferase
- Squalene monooxygenase
- Lanosterol synthase
|
|
7-Dehydrocholesterol path |
- Lanosterol 14α-demethylase
- Sterol-C5-desaturase-like
- 7-Dehydrocholesterol reductase
|
|
Desmosterol path |
- 24-dehydrocholesterol reductase
|
|
|
To Bile acids |
- Cholesterol 7α-hydroxylase
- Sterol 27-hydroxylase
|
|
Steroidogenesis |
To pregnenolone |
|
|
To corticosteroids |
- aldosterone: 18-hydroxylase
- cortisol/cortisone: 17α-hydroxylase
- 11β dehydrogenase
- both: 3β dehydrogenase
- 21α-hydroxylase
- 11β-hydroxylase
|
|
To sex hormones |
To androgens |
- 17α-hydroxylase/17,20 lyase
- 3β dehydrogenase
- 17β dehydrogenase
- 5α reductase
|
|
To estrogens |
|
|
|
Other/ungrouped |
- Steroid metabolism: sulfatase
- sulfotransferase
- Steroidogenic acute regulatory protein
- Cholesterol total synthesis
- Reverse cholesterol transport
|
|
|
Index of inborn errors of metabolism
|
|
Description |
- Metabolism
- Enzymes and pathways: citric acid cycle
- pentose phosphate
- glycoproteins
- glycosaminoglycans
- phospholipid
- cholesterol and steroid
- sphingolipids
- eicosanoids
- amino acid
- urea cycle
- nucleotide
|
|
Disorders |
- Citric acid cycle and electron transport chain
- Glycoprotein
- Proteoglycan
- Fatty-acid
- Phospholipid
- Cholesterol and steroid
- Eicosanoid
- Amino acid
- Purine-pyrimidine
- Heme metabolism
- Symptoms and signs
|
|
Treatment |
|
Index of hormones
|
|
Description |
- Glands
- Hormones
- thyroid
- mineralocorticoids
- Physiology
- Development
|
|
Disease |
- Diabetes
- Congenital
- Neoplasms and cancer
- Other
- Symptoms and signs
|
|
Treatment |
- Procedures
- Drugs
- calcium balance
- corticosteroids
- oral hypoglycemics
- pituitary and hypothalamic
- thyroid
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Titanium dioxide nanoparticle-induced testicular damage, spermatogenesis suppression, and gene expression alterations in male mice.
- Gao G, Ze Y, Zhao X, Sang X, Zheng L, Ze X, Gui S, Sheng L, Sun Q, Hong J, Yu X, Wang L, Hong F, Zhang X.SourceMedical College of Soochow University, Suzhou 215123, China.
- Journal of hazardous materials.J Hazard Mater.2013 Aug 15;258-259:133-43. doi: 10.1016/j.jhazmat.2013.04.046. Epub 2013 May 6.
- Although titanium dioxide nanoparticles (TiO2 NPs) have been demonstrated to accumulate in organs resulting in toxicity, there is currently only limited data regarding male reproductive toxicity by TiO2 NPs. In this study, testicular damage and alterations in gene expression profiles in male mice in
- PMID 23721730
- Performance of in silico analysis in predicting the effect of non-synonymous variants in inherited steroid metabolic diseases.
- Chan AO.SourceDivision of Clinical Biochemistry, Queen Mary Hospital, Hong Kong Special Administrative Region. Electronic address: cok436@ha.org.hk.
- Steroids.Steroids.2013 Jul;78(7):726-30. doi: 10.1016/j.steroids.2013.04.002. Epub 2013 Apr 17.
- BACKGROUND: Unclassified genetic variants are commonly encountered in molecular diagnostic service. In silico analyses using web-based predictive programs may provide information on the nature of the genetic variants, and help to prioritize novel variants for in vitro functional characterization. Th
- PMID 23603282
- Molecular diagnosis of 5α-reductase deficiency in 4 elite young female athletes through hormonal screening for hyperandrogenism.
- Fénichel P, Paris F, Philibert P, Hiéronimus S, Gaspari L, Kurzenne JY, Chevallier P, Bermon S, Chevalier N, Sultan C.SourceMD, PhD, Researcher, Institut National de la Santé et de la Recherche Médicale and Nice University Department of Endocrinology, 06200 Nice, France. fenichel.p@chu-nice.fr.
- The Journal of clinical endocrinology and metabolism.J Clin Endocrinol Metab.2013 Jun;98(6):E1055-9. doi: 10.1210/jc.2012-3893. Epub 2013 Apr 30.
- Context: Although a rare occurrence, previously undiagnosed disorders of sex development (DSD) with hyperandrogenism are sometimes detected by hormonal screening during the international sports competitions. Identifying the cause of XY,DSD raises medical and ethical concerns, especially with regard
- PMID 23633205
Japanese Journal
- Novel compound heterozygous mutations in the SRD5A2 gene from 46,XY infants with ambiguous external genitalia
- Vilchis Felipe,Valdez Evangelina,Ramos Luis [他],GARCIA Rocio,GOMEZ Rita,CHAVEZ Bertha
- Journal of human genetics 53(5), 401-406, 2008-05-01
- NAID 10021248793
- Mutational Analysis of Androgen Receptor (AR) Gene in 46, XY Patients with Ambiguous Genitalia and Normal Testosterone Secretion : Endocrinological Characteristics of Three Patients with AR Gene Mutations
- Miyamoto Junko,Asanuma Hiroshi,Nakai Hideo,Hasegawa Tomonobu,Nawata Hajime,Hasegawa Yukihiro
- Clinical pediatric endocrinology 15(4), 151-162, 2006-10
- NAID 110006794334
- Genotype Frequencies of 50 Polymorphisms for 241 Japanese Non-cancer Patients
- HAMAJIMA Nobuyuki,SAITO Toshiko,MATSUO Keitaro,SUZUKI Takashi,NAKAMURA Tsuneya,MATSUURA Akio,OKUMA Katashi,TAJIMA Kazuo
- Journal of epidemiology 12(3), 229-236, 2002-05
- … MPO, MTR, MTHFR, MAO-A, NQO1, OGG1, p53, p73, Se, SRD5A2, TGF-B, TNF-A, TNF-B, XPD, and XRCC1)and 6 sets of combined genotype frequencies for 241 non-cancer Japanese outpatients.Though the genotype frequencies of 25 polymorphisms have already been reported in our previous papers, 15 polymorphisms(CD36 A52C, CXCR2 C785T, CCND1 G870A, IGF1 C/T at intron 2 and G2502T, IL-1A 46-bp VNTR, IL1R1 C-1 16T, IL-6 Ins/Del 17C, IL-8 A-278T and C74T, IL10 T-819C, LEP A-2548G, SRD5A2 2bp VNTR, XPD Lys751GIn, and XRCC1 Arg399Gln)and six …
- NAID 130000797578
Related Links
- The official name of this gene is “steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2).” SRD5A2 is the gene's official symbol. The SRD5A2 gene is also known by other ...
- Complete information for SRD5A2 gene (protein-coding), steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alp..., including: function, proteins, disorders, pathways, orthologs, and expression.
Related Pictures
★リンクテーブル★
[★]
- 英
- testosterone 5alpha-reductase、SRD5A2
- 関
- テストステロン5α-還元酵素、テストステロン5αレダクターゼ、テストステロン5α-レダクターゼ
[★]
テストステロン5α還元酵素、テストステロン5αレダクターゼ
- 関
- SRD5A2、testosterone 5-alpha-reductase